US: 800.298.5699
Int'l: +1.240.747.3093
 
Matching geography
Reports matching your search in:
 
 
Join Alert Me now!
Receive bi-weekly email alerts on new market research

Sign up today!
 

Women's Health Market Research Reports & Industry Analysis

Women’s health is a perspective of prevention and treatment that looks at health concerns unique to females. Even though slightly more than half of the US population is female, medical research historically has neglected the health needs of women, other than reproductive issues. Recently there have been major changes in government and private support of women’s health research -- in policies, regulations, and the organization of research efforts.
In a recent Institute of Medicine (IOM) report, the Washington DC-based institute found that women’s health research has contributed to significant progress over the past 20 years in lessening the burden of disease and reducing deaths from some conditions for women, while other conditions have seen only moderate change or even little or no change. Gaps remain, both in research areas and in the application of results to benefit women in general and across multiple population groups.

Viewing women’s health exclusively as a function of sex differences is too narrow, according to the IOM report. It frames women’s health and well-being as a function only of biological factors and how they differ in men and women, and ignores the role of gender, which is affected by broader social and community factors. The IOM finds that there has been inadequate attention paid to the social and environmental factors that, along with biologic risk factors, influence women’s health. Although progress has been made in identifying behavioral determinants of women’s health, such as smoking, diet, and physical activity, few studies have tested ways to modify these determinants in women or examined the effects of social and community factors in specific groups of women. To advance this area of research, the IOM recommends that the National Institutes of Health (NIH) support research on common determinants and risk factors that underlie multiple diseases.

Significant progress has been made in reducing mortality for women from breast cancer, cardiovascular disease and cervical cancer. This can be attributed in part to increased consumer demand and awareness, which has resulted in additional funding and research; improved diagnosis; screening and treatment; and, in the case of cervical cancer, a vaccine.

RSS Feeds

Women's Health Industry Research & Market Reports

< prev 1    3  4  5  6  7  8  9  10  
Ovarian Cancer Drug Pathway Analyzer 2015
1/12/2015 | published by: BioSeeker Group AB
... ovarian cancer. The rational for this plethora of treatment strategies is based on our increasing understanding of the 254 drug targets that are included in this drug-pathway analyzing tool. No less than 249 of these ...  |  read more...
USD 6,746
Breast Cancer Drug Pathway Analyzer 2015
1/12/2015 | published by: BioSeeker Group AB
... breast cancer. The rational for this plethora of treatment strategies is based on our increasing understanding of the 322 drug targets that are included in this drug-pathway analyzing tool. No less than 316 of these ...  |  read more...
USD 6,746
Trichomonas Vaginitis Global Clinical Trials Review, H2, 2014
12/31/2014 | published by: GlobalData
... information and data relating to the clinical trials on Trichomonas Vaginitis. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook ...  |  read more...
USD 2,500
Bacterial Vaginosis - Pipeline Review, H2 2014
12/24/2014 | published by: Global Markets Direct
... therapeutic development for Bacterial Vaginosis, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news ...  |  read more...
USD 2,000
Global Combined Hormonal Contraceptives (CHC) Market: Trends and Opportunities (2014-19)
1/1/2015 | published by: Daedal Research
... CHC market with detailed analysis of market sizing and growth, market share and economic impact of the industry. The report also assesses key opportunities in the market and outlines the factors that are and will ...  |  read more...
USD 800
Cervical Dysplasia - Pipeline Review, H2 2014
12/31/2014 | published by: Global Markets Direct
... therapeutic development for Cervical Dysplasia, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news ...  |  read more...
USD 2,000
Breast Cancer Drug Pipeline Update 2015
1/5/2015 | published by: BioSeeker Group AB
... below five years. There are today 400 companies plus partners developing 540 drugs targeting breast cancer in development. In addition, there are 8 suspended drugs and the accumulated number of ceased drugs over the last ...  |  read more...
USD 6,746
Global Ovarian Cancer Epidemiology and Patient Flow Analysis - 2015
1/9/2015 | published by: Fore Pharma
... - 2015’. The report provides insights into Ovarian Cancer epidemiology, Ovarian Cancer diagnosed patients, and Ovarian Cancer treatment rate for top seven pharmaceutical markets. The study measures key indicators such as prevalence of Ovarian Cancer ...  |  read more...
USD 1,200
Human Papillomavirus Infections Global Clinical Trials Review, H2, 2014
12/22/2014 | published by: GlobalData
... report provides elemental information and data relating to the clinical trials on Human Papillomavirus Infections. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across ...  |  read more...
USD 2,500
Vulvovaginal Candidiasis Global Clinical Trials Review, H2, 2014
12/31/2014 | published by: GlobalData
... information and data relating to the clinical trials on Vulvovaginal Candidiasis. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook ...  |  read more...
USD 2,500
2015 Market Research Report on Global Breast Pump Industry
1/1/2015 | published by: QYResearch Group
... application, industry chain structure, industry overview, policy analysis, and news analysis, etc For international and China market analysis, the report analyzes Breast Pump markets in China and other countries or regions (such as US, Europe, ...  |  read more...
USD 2,600
Ureter Cancer - Pipeline Review, H2 2014
12/31/2014 | published by: Global Markets Direct
... therapeutic development for Ureter Cancer, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news ...  |  read more...
USD 2,000
Dysmenorrhea - Pipeline Review, H2 2014
12/31/2014 | published by: Global Markets Direct
... Dysmenorrhea, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It ...  |  read more...
USD 2,000
Global Cervical Cancer Epidemiology and Patient Flow Analysis - 2015
1/9/2015 | published by: Fore Pharma
... - 2015’. The report provides insights into Cervical Cancer epidemiology, Cervical Cancer diagnosed patients, and Cervical Cancer treatment rate for top seven pharmaceutical markets. The study measures key indicators such as prevalence of Cervical Cancer ...  |  read more...
USD 1,200
Ovarian Cancer Drug Pipeline Update 2015
1/5/2015 | published by: BioSeeker Group AB
... pipeline drugs. There are today 257 companies plus partners developing 348 drugs targeting ovarian cancer in development. In addition, there are 6 suspended drugs and the accumulated number of ceased drugs over the last years ...  |  read more...
USD 6,746
2015 Global Papillomavirus Diagnostics Market: Growth Opportuinites and Business Expansion Strategies
1/8/2015 | published by: VPGMarketResearch.com
... scientific views on the Papillomavirus definition, epidemiology and etiology are reviewed. The report provides the 5- and 10-year test volume and sales forecasts by country for the following market segments: - Hospitals - Commercial/Private Labs ...  |  read more...
USD 4,350
Vasomotor Symptoms of Menopause - Pipeline Review, H2 2014
11/14/2014 | published by: Global Markets Direct
... report provides comprehensive information on the therapeutic development for Vasomotor Symptoms of Menopause, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule ...  |  read more...
USD 2,000
Osteoarthritis Pipeline Highlights – 2015
11/5/2014 | published by: Fore Pharma
... clinical development stages including early and late stage clinical trials. The pipeline data presented in this report helps executives for tracking competition, identifying partners, evaluating opportunities, formulating business development strategies, and executing in-licensing and out-licensing ...  |  read more...
USD 670
Uterine cancer Pipeline Highlights – 2015
11/5/2014 | published by: Fore Pharma
... Uterine cancer in active clinical development stages including early and late stage clinical trials. The pipeline data presented in this report helps executives for tracking competition, identifying partners, evaluating opportunities, formulating business development strategies, and ...  |  read more...
USD 670
Cervical Dysplasia Pipeline Highlights – 2015
11/5/2014 | published by: Fore Pharma
... Cervical Dysplasia in active clinical development stages including early and late stage clinical trials. The pipeline data presented in this report helps executives for tracking competition, identifying partners, evaluating opportunities, formulating business development strategies, and ...  |  read more...
USD 670
Breast Cancer - Pipeline Review, H2 2014
11/18/2014 | published by: Global Markets Direct
... therapeutic development for Breast Cancer, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news ...  |  read more...
USD 2,500
Global Cervical Cancer Diagnostic Tests Market 2014-2018
12/17/2014 | published by: TechNavio - Infiniti Research Ltd.
... These tests include an initial screening using pap smear and HPV testing, and upon positive results, colposcopy and biopsy are further utilized to confirm the diagnosis. After the positive diagnosis, the patient is further subjected ...  |  read more...
USD 2,500
Condom Market in the US 2015-2019
12/17/2014 | published by: TechNavio - Infiniti Research Ltd.
... also widely recommended for the prevention of STIs. As a method of birth control, male condoms have the advantage of being inexpensive and easy to use. They also have minimal side effects and offer protection ...  |  read more...
USD 2,500
Breast Cancer-API Insights, 2014
11/21/2014 | published by: DelveInsight
... drugs going off patent in the coming years. It is going to affect the revenue of the API market as generic drugs occupy the market. India and China produce a large percentage of a majority ...  |  read more...
USD 1,250
Ovarian Cancer-API Insights, 2014
11/21/2014 | published by: DelveInsight
... drugs going off patent in the coming years. It is going to affect the revenue of the API market as generic drugs occupy the market. India and China produce a large percentage of a majority ...  |  read more...
USD 1,250
< prev 1    3  4  5  6  7  8  9  10